Functional neural transplantation IV : translation to clinical application. Part A /

• Άλλοι συγγραφείς: Dunnett, S. B. (Stephen B.) (Επιμελητής έκδοσης), Björklund, Anders (Επιμελητής έκδοσης)
• Μορφή: Ηλ. βιβλίο
• Γλώσσα: English
• Έκδοση: Cambridge, MA : Academic Press is an imprint of Elsevier, 2017.
• Έκδοση: First edition.
• Σειρά: Progress in brain research ; v. 230.
• Θέματα: Stem cells > Transplantation.; Brain > Regeneration.; HEALTH & FITNESS / Diseases / General; MEDICAL / Clinical Medicine; MEDICAL / Diseases; MEDICAL / Evidence-Based Medicine; MEDICAL / Internal Medicine; Stem Cell Transplantation > methods.; Nervous System Diseases > therapy.; Neurodegenerative Diseases > therapy.; Brain Injuries > therapy.; Nerve Regeneration.; Electronic books.
• Φυσική περιγραφή: 1 online resource (xxvii, 353 pages) : illustrations (chiefly color).
• Βιβλιογραφία: Includes bibliographical references and index.
• ISBN: 9780128118139; 012811813X; 9780128117385; 0128117389
• ISSN: 0079-6123 ;

"Functional Neural Transplantation IV: Translation to Clinical Application, Volume 230 provides a survey of the current status of cell transplantation in the nervous system, with a focus on the conditions for achieving structural repair and functional recovery after brain damage or in neurodegenerative disease. As the fourth in a periodic series of updates at 5-7 year intervals, this volume highlights recent developments related to the application of advances in cellular and molecular science to an understanding of the fundamental principles of neuroplasticity and regeneration in the brain and spinal cord, also addressing the topic of the power of pluripotent stem cells to generate new sources of precisely specified neurons for utilization in brain repair. Selected chapters review the latest advances in translating the new technologies to a broader range of neurodegenerative diseases, stroke, spinal cord injury, glial and retinal disease and pain than had hitherto been considered possible, with the realization that the opportunities of off-the-shelf cell therapy may fast be approaching a plausible reality"--Publisher's description.